Investing.com

The USD/CAD currency pair is currently encountering resistance around the 1.36 level. Buyers have been consistently testing this level in recent weeks, indicating potential upward pressure. A...

The S&P 500 index surged in the first quarter, with nearly half of this growth attributed to select top-performing stocks like Nvidia. Amid this trend, it's crucial to consider the cyclical nature...

Despite industry challenges, LVMH has consistently surpassed expectations, maintaining steady economic growth by diversifying its portfolio. With iconic brands like Dior and Louis Vuitton under its...

The PCE data met expectations on Friday, with Powell's remarks having minimal impact on market sentiment heading into the new week. Speculation surrounding a potential Fed interest rate cut in June...

Let's take a look at up to 8 reasons why a dip-buying strategy could be the best way to take advantage of bullish momentum. Meanwhile, gold is benefiting from record central bank buying, apart from...

In Thursday’s session, which was the last trading day of FY24, the Indian benchmark Nifty 50 index remarkably rallied by over 393 points as investor’s enthusiasm sparked a buying frenzy....

U.S. jobs report, PMI surveys, Fed speakers will be in focus this week. Fortinet is a buy as its annual ‘Accelerate 2024’ event kicks off. Tesla is a sell with weak Q1 deliveries...

The final estimate for Q4 GDP growth in the U.S. is revised up to 3.4%, fueled by robust consumer spending and nonresidential fixed investment. A slight decrease in jobless claims to 210,000 further...

The S&P 500 closed out a blowout month and quarter at a new record high to notch its best start to a year since 2019. Identifying promising opportunities becomes paramount amid the current...

After a sluggish 2023, 2024 looks brighter for healthcare stocks. Numerous demographic and social factors also argue in favor of a long-term rise. What are the best healthcare stocks to buy...

Despite a challenging year with a stock price drop of over 41%, ACADIA Pharmaceuticals is seen by InvestingPro and Wall Street analysts as undervalued, with expectations of significant upside...

Today, we'll explore stocks offering promising dividends alongside potential growth opportunities and market favor. These stocks embody a coveted blend of strong dividends, promising earnings,...

Central Banks had a big impact on gold and silver last week. Gold futures have made new highs - and traders should watch out for a potential correction because of PCE, GDP data. Meanwhile, silver...

Humana's stock has seen a 24% drop YTD due to slashed profit forecasts. Wall Street responded with analyst downgrades and lowered EPS expectations ahead of the Q1 report. Despite challenges,...

The S&P 500 is off to a strong start to the year, topping the 5,200-level for the first time ever. The benchmark index is set to extend its record rally amid favorable market conditions. As such,...

Walgreens' declining profits are fueling bearish sentiment. Can the new CEO orchestrate a turnaround? Meanwhile, the stock's downward trajectory persists. In 2024, invest like the big funds from the...